A comparative PET imaging study with the reversible and irreversible EGFR tyrosine kinase inhibitors [C-11]erlotinib and [F-18]afatinib in lung cancer-bearing mice

P. Slobbe, A.D. Windhorst, M. Stigter-van Walsum, E.F. Smit, H.G. Niessen, F. Solca, G Stehle, G.A.M.S. van Dongen, A.J. Poot

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Article number14
JournalEJNMMI Research
Volume5
DOIs
Publication statusPublished - 2015

Cite this

@article{a41d168df27f447283d168005e9d1900,
title = "A comparative PET imaging study with the reversible and irreversible EGFR tyrosine kinase inhibitors [C-11]erlotinib and [F-18]afatinib in lung cancer-bearing mice",
author = "P. Slobbe and A.D. Windhorst and {Stigter-van Walsum}, M. and E.F. Smit and H.G. Niessen and F. Solca and G Stehle and {van Dongen}, G.A.M.S. and A.J. Poot",
year = "2015",
doi = "10.1186/s13550-015-0088-0",
language = "Undefined/Unknown",
volume = "5",
journal = "EJNMMI Research",
issn = "2191-219X",
publisher = "Springer Berlin",

}

A comparative PET imaging study with the reversible and irreversible EGFR tyrosine kinase inhibitors [C-11]erlotinib and [F-18]afatinib in lung cancer-bearing mice. / Slobbe, P.; Windhorst, A.D.; Stigter-van Walsum, M.; Smit, E.F.; Niessen, H.G.; Solca, F.; Stehle, G; van Dongen, G.A.M.S.; Poot, A.J.

In: EJNMMI Research, Vol. 5, 14, 2015.

Research output: Contribution to journalArticleAcademicpeer-review

TY - JOUR

T1 - A comparative PET imaging study with the reversible and irreversible EGFR tyrosine kinase inhibitors [C-11]erlotinib and [F-18]afatinib in lung cancer-bearing mice

AU - Slobbe, P.

AU - Windhorst, A.D.

AU - Stigter-van Walsum, M.

AU - Smit, E.F.

AU - Niessen, H.G.

AU - Solca, F.

AU - Stehle, G

AU - van Dongen, G.A.M.S.

AU - Poot, A.J.

PY - 2015

Y1 - 2015

U2 - 10.1186/s13550-015-0088-0

DO - 10.1186/s13550-015-0088-0

M3 - Article

VL - 5

JO - EJNMMI Research

JF - EJNMMI Research

SN - 2191-219X

M1 - 14

ER -